Glucocorticoid-Induced Bone Disease
- 7 July 2011
- journal article
- review article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 365 (1), 62-70
- https://doi.org/10.1056/nejmcp1012926
Abstract
This article reviews the risks of osteoporosis and osteonecrosis associated with glucocorticoid use, which are present even in the absence of low bone mineral density, and discusses strategies to reduce the risk of fractures and the data to support the strategies.Keywords
This publication has 44 references indexed in Scilit:
- Age Dependence of Early Symptomatic Vertebral Fracture with High-Dose Glucocorticoid Treatment for Collagen Vascular DiseasesJournal of Clinical Endocrinology & Metabolism, 2009
- Glucocorticoid-induced osteoporosis: pathophysiology and therapyOsteoporosis International, 2007
- High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: A cross-sectional outpatient studyBone, 2006
- Two Polymorphisms in the Glucocorticoid Receptor Gene Directly Affect Glucocorticoid-Regulated Gene ExpressionJournal of Clinical Endocrinology & Metabolism, 2005
- Oral glucocorticoid use is associated with an increased risk of fractureOsteoporosis International, 2004
- Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapyArthritis & Rheumatism, 2003
- Osteoblastic 11β-Hydroxysteroid Dehydrogenase Type 1 Activity Increases With Age and Glucocorticoid ExposureJournal of Bone and Mineral Research, 2002
- Use of Inhaled Corticosteroids and Risk of FracturesJournal of Bone and Mineral Research, 2001
- Not All Postmenopausal Women on Chronic Steroid and Estrogen Treatment are Osteoporotic: Predictors of Bone Mineral DensityCalcified Tissue International, 1997
- Bone loss in response to long-term glucocorticoid therapyBone and Mineral, 1990